IRIS - Res&Arch Institutional Research Information System - Research & Archive

DESANTIS, JENNY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.208
AS - Asia 1.081
EU - Europa 795
SA - Sud America 142
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 26
OC - Oceania 2
Totale 3.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.158
SG - Singapore 406
IT - Italia 241
VN - Vietnam 193
CN - Cina 157
HK - Hong Kong 137
RU - Federazione Russa 119
IE - Irlanda 113
BR - Brasile 109
DE - Germania 61
FR - Francia 48
BD - Bangladesh 47
SE - Svezia 38
FI - Finlandia 37
CA - Canada 31
IN - India 29
KR - Corea 27
BE - Belgio 26
GB - Regno Unito 22
NL - Olanda 16
PL - Polonia 16
JP - Giappone 14
IQ - Iraq 13
AR - Argentina 12
TR - Turchia 11
AT - Austria 10
ES - Italia 9
ID - Indonesia 9
MX - Messico 9
UA - Ucraina 8
PK - Pakistan 7
ZA - Sudafrica 7
LT - Lituania 6
SA - Arabia Saudita 6
UZ - Uzbekistan 5
VE - Venezuela 5
CH - Svizzera 4
EC - Ecuador 4
RO - Romania 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BO - Bolivia 1
CV - Capo Verde 1
GY - Guiana 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MC - Monaco 1
MU - Mauritius 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.256
Salva come PNG Salva come JPEG
Città #
Singapore 296
Chandler 186
Hong Kong 130
San Jose 130
Dublin 113
Dong Ket 100
Ashburn 93
Perugia 91
Santa Clara 56
Beijing 52
Boardman 50
Moscow 43
Munich 39
San Mateo 39
Los Angeles 35
The Dalles 32
Ho Chi Minh City 30
Lauterbourg 28
Brussels 26
New York 26
Seoul 26
Altamura 23
Hanoi 22
Lawrence 21
Medford 21
Princeton 21
Helsinki 18
Rome 12
Denver 11
Orem 11
Piscataway 11
Wilmington 11
Montreal 10
Tokyo 10
Turku 10
West Jordan 10
Andover 9
Atlanta 9
Buffalo 9
Fremont 8
Milan 8
Warsaw 8
Council Bluffs 7
Da Nang 7
Dallas 7
San Francisco 7
Chicago 6
Hefei 6
Mumbai 6
Phoenix 6
Saint Petersburg 6
Stockholm 6
Toronto 6
Ankara 5
Chennai 5
Norwalk 5
Nuremberg 5
Portogruaro 5
São Paulo 5
Des Moines 4
Dhaka 4
Florence 4
Houston 4
Isorella 4
Jakarta 4
Johannesburg 4
Lappeenranta 4
Mexico City 4
Newark 4
Porto Alegre 4
Poznan 4
Redwood City 4
Rio de Janeiro 4
Salvador 4
Secaucus 4
Shanghai 4
Spoleto 4
Tashkent 4
Vienna 4
Zhengzhou 4
Abidjan 3
Addis Ababa 3
Amsterdam 3
Baku 3
Brasília 3
Brooklyn 3
Calgary 3
City of London 3
Columbus 3
Curitiba 3
Erbil 3
Hải Dương 3
Jeddah 3
Lahore 3
London 3
Loreto 3
Redmond 3
San Paolo di Civitate 3
Siena 3
Vancouver 3
Totale 2.138
Salva come PNG Salva come JPEG
Nome #
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 337
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 149
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 142
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 136
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 133
PROTACs bearing piperazine-containing linkers: what effect on their protonation state? 125
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 124
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 120
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications 120
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 118
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 115
VHL-Modified PROteolysis TArgeting Chimeras (PROTACs) as a Strategy to Evade Metabolic Degradation in In Vitro Applications 112
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 111
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 111
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs 104
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 104
CROMATIC: Cross-Relationship Map of Cavities from Coronaviruses 102
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 102
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase 101
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design 98
Effects of MTX-23, a novel PROTAC of androgen receptor splice variant-7 and androgen receptor, on CRPC resistant to second-line antiandrogen therapy 95
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 89
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib 81
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis 72
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 70
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 70
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 68
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 66
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 65
Proteolysis targeting chimeras in antiviral research 50
Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV 43
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer 21
LC‐MS and High‐Throughput Data Processing Solutions for Lipid Metabolic Tracing Using Bioorthogonal Click Chemistry 18
Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease 8
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies 7
Totale 3.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022171 0 27 2 9 3 1 3 45 20 5 34 22
2022/2023479 22 100 16 49 36 50 0 27 158 2 16 3
2023/2024271 11 41 10 9 5 7 61 3 14 27 39 44
2024/2025662 10 73 23 42 70 50 88 28 118 44 79 37
2025/20261.416 85 107 65 171 199 118 244 77 152 97 50 51
2026/202776 38 38 0 0 0 0 0 0 0 0 0 0
Totale 3.387